NIAID launches microbicide development research. National Institutes of Allergy and Infectious Diseases.
D000282:Administration, Intravaginal; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D009316:National Institutes of Health (U.S.); D012106:Research; D012749:Sexually Transmitted Diseases / Q000517:prevention & control*; D014481:United States
D000891:Anti-Infective Agents, Local